Ratio Analysis: Unpacking Longboard Pharmaceuticals Inc (LBPH)’s Price-to-Cash and Price-to-Free Cash Flow

Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $35.33 in the prior trading day, Longboard Pharmaceuticals Inc (NASDAQ: LBPH) closed at $33.60, down -4.90%. In other words, the price has decreased by -$4.90 from its previous closing price. On the day, 1.03 million shares were traded. LBPH stock price reached its highest trading level at $35.5 during the session, while it also had its lowest trading level at $33.53.

Ratios:

Our goal is to gain a better understanding of LBPH by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 20.95 and its Current Ratio is at 20.95. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on September 10, 2024, initiated with a Buy rating and assigned the stock a target price of $60.

On July 01, 2024, Cantor Fitzgerald reiterated its Overweight rating and also lowered its target price recommendation from $60 to $90.

On May 01, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $36.Robert W. Baird initiated its Outperform rating on May 01, 2024, with a $36 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 23 ’24 when Kaye Randall bought 100 shares for $24.82 per share. The transaction valued at 2,482 led to the insider holds 100 shares of the business.

Kaye Randall sold 16,667 shares of LBPH for $578,804 on Aug 12 ’24. The CMO now owns 17,920 shares after completing the transaction at $34.73 per share. On Jun 25 ’24, another insider, Kaye Randall, who serves as the CMO of the company, sold 100 shares for $20.87 each. As a result, the insider received 2,087 and left with 0 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LBPH now has a Market Capitalization of 1374730496 and an Enterprise Value of 1006012928.

Stock Price History:

Over the past 52 weeks, LBPH has reached a high of $40.48, while it has fallen to a 52-week low of $3.60. The 50-Day Moving Average of the stock is -4.22%, while the 200-Day Moving Average is calculated to be 50.90%.

Shares Statistics:

The stock has traded on average 640.78K shares per day over the past 3-months and 537920 shares per day over the last 10 days, according to various share statistics. A total of 38.90M shares are outstanding, with a floating share count of 33.46M. Insiders hold about 13.98% of the company’s shares, while institutions hold 99.70% stake in the company. Shares short for LBPH as of 1723680000 were 4839590 with a Short Ratio of 7.55, compared to 1721001600 on 4466915. Therefore, it implies a Short% of Shares Outstanding of 4839590 and a Short% of Float of 16.440001000000002.

Most Popular